Eli Lilly (LLY) reported Q4 non-GAAP earnings Thursday of $5.32 per diluted share, up from $2.49 a year earlier.

Analysts polled by FactSet expected $5.01.

Revenue for the quarter ended Dec. 31 was $13.53 billion, up from $$9.35 billion a year earlier.

Analysts surveyed by FactSet expected $13.53 billion.

For 2025, the company said it expects non-GAAP EPS of $22.50 to $24 on revenue of $58 billion to $61 billion.

Analysts polled by FactSet expect non-GAAP EPS of $22.76 on $58.77 billion in revenue.

The company's shares were up nearly 3% in recent Thursday premarket activity.